was vital farms able to retain existing buyers and only had problem with new buyers? in q1 2026

Yes, that is exactly what happened in Q1 2026. While Vital Farms had previously enjoyed strong growth across both segments, the first quarter of 2026 marked a distinct shift where new customer acquisition stalled, but existing brand loyalty remained incredibly resilient.

Based on their Q1 2026 earnings call, here is the breakdown of their buyer dynamics:

Existing Buyer Retention

Vital Farms successfully retained its existing customer base, proving the "stickiness" of their brand among loyalists.

• Strong Buy Rates: The company reported that existing consumers generally resisted trading down to lower-priced alternatives.
• Increased Volume: The units per retained household actually rose by 2% in the first quarter of 2026 compared to the average over the previous eight quarters.

The Problem with New Buyers

The company faced significant headwinds in converting brand awareness into trial purchases among new households.

• Drop in New Trials: In 2024 and 2025, more than 55% of Vital Farms' consumers were households that had never bought their products before. In Q1 2026, that number dropped to just 50%.
• Slowdown in Velocity: Management explicitly noted that this slowdown in new consumer acquisition directly impacted their overall market velocity and contributed to their earnings miss.

The Root Cause: A Massive Price Gap

The divergence between retaining old buyers and acquiring new ones in Q1 2026 came down to a drastic shift in the broader egg market.

Following a much milder avian influenza season, industry flocks were rebuilt, causing commodity egg prices to plummet to around $2 per dozen at retail. Vital Farms, meanwhile, maintained their premium pricing (roughly $8 per dozen). For new consumers looking to try the brand, a roughly $6 premium proved to be too steep a hurdle. However, for existing consumers who were already accustomed to paying a premium for pasture-raised, ethical eggs, the price gap was not enough to make them abandon the brand.

To address the lack of new trials, management stated their immediate focus going forward is to reduce these price gaps and manage the current oversupply of egg inventory.